We are live on
!
Find out more
Regeneron Pharmaceuticals
REGN
REGN
1,063 hedge funds and large institutions have $54.7B invested in Regeneron Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 93 funds opening new positions, 376 increasing their positions, 416 reducing their positions, and 110 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 22 → 22 (0)
0.46% less ownership
Funds ownership: 86.65% → 86.18% (-0.46%)
10% less repeat investments, than reductions
Existing positions increased: 376 | Existing positions reduced: 416
3% less funds holding
Funds holding: 1,094 → 1,063 (-31)
15% less capital invested
Capital invested by funds: $64.2B → $54.7B (-$9.46B)
15% less first-time investments, than exits
New positions opened: 93 | Existing positions closed: 110
27% less call options, than puts
Call options by funds: $707M | Put options by funds: $974M
Holders
1,063
Holders Change
-31
Holders Change %
-2.83%
% of All Funds
17.91%
Holding in Top 10
22
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.37%
New
93
Increased
376
Reduced
416
Closed
110
Calls
$707M
Puts
$974M
Net Calls
-$267M
Net Calls Change
+$159M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$529M |
| 2 |
JP Morgan Chase
New York
|
+$464M |
| 3 |
Renaissance Technologies
New York
|
+$197M |
| 4 |
Morgan Stanley
New York
|
+$195M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$185M |
Top Sellers
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$509M |
| 2 |
Harris Associates
Chicago,
Illinois
|
-$332M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$330M |
| 4 |
Two Sigma Investments
New York
|
-$145M |
| 5 |
Two Sigma Advisers
New York
|
-$137M |
